• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

Shingrix™ (herpes zoster vaccine)

	Next higher product group	vaccine_oo
	Status	2017-10-13 registration start
	Organisation	GSK (Group)

Record changed: 2022-11-22

Advertisement

More documents for Shingrix™ (herpes zoster vaccine)

• [1] Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain....
• [2] GlaxoSmithKline plc. (1/26/18). "Press Release: GSK’s Shingrix Receives Positive Opinion from the CHMP in Europe for the Prevention of Shingles in Adults Aged 50 and Over". London....
• [3] GlaxoSmithKline plc. (10/25/17). "Press Release: CDC’s Advisory Committee on Immunization Practices Recommends Shingrix as the Preferred Vaccine for the Prevention of Shingles for Adults Aged 50 and Up". London....
• [4] GlaxoSmithKline plc. (10/23/17). "Press Release: Shingrix Approved in the US for Prevention of Shingles in Adults Aged 50 and Over". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2023. Made in Germany.